Delivery Order SPE2DP16D0006-0002
Award Date 7/1/16
Potential Completion Date 10/17/16
Potential Value $9M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
- This federal contract award for $2,408,448.00 was issued by the Medical Supply Chain division of the U.S. Department of Defense to the pharmaceutical company Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The contract is a firm fixed price delivery order with no set-aside designation, and performance will occur at Glaxosmithkline's facilities in North Carolina. This award is part of a larger indefinite delivery vehicle (IDV) contract held by Glaxosmithkline to provide a range...
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0456, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The contract is a firm fixed-price Delivery Order with a ceiling value of $173,368.80 and a period of performance ending on November 8, 2018. The contract was not set aside for any specific business designation. Glaxosmithkline, LLC has provided a range of pharmaceutical goods and...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of flu vaccine, with a potential value of $266,760.00 and a completion date of January 9, 2020. The contract is a firm fixed price Delivery Order with no set-aside designation. Glaxosmithkline has...
- This federal contract award, with ID SPE2DP16D0006|0005, was issued by the Medical Supply Chain division of the Defense Logistics Agency to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The $282,870.56 firm fixed price delivery order has an ultimate completion date of November 30, 2016 and does not have a set-aside designation. Glaxosmithkline, LLC is a prime contractor that has received various federal contract and grant awards to supply...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), which is part of the U.S. Department of Veterans Affairs (VA), to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of influenza vaccines. The contract has a ceiling value of $264,525.30 and is a firm fixed price delivery order with no set-aside designation. The contract supports flu prevention and immunization programs for the VA. Glaxosmithkline, LLC has also received other...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- This federal contract award with ID SPE2DP24D0005|SPE2DP24F3249 is for the delivery of influenza virus vaccines. The contract was awarded on March 14, 2024 to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The contract has a ceiling value of $1,551,550.00 and is a firm fixed price delivery order contract with no set-aside designation. The...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of flu vaccines. The $319,475 firm fixed-price delivery order contract has an October 15, 2017 completion date and was awarded on March 30, 2017. The contract did not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies through federal contracts...